Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
noviSplet logo โ€” Digitalna agencija, specializirana za izdelavo spletnih stra...

noviSplet

Digitalna agencija, specializirana za izdelavo spletnih strani in B2B/B2C trgovin z veฤ kot 1500 referencami. ๐ŸŒ๐Ÿ’ก๐Ÿš€

Founded 2004 Slovenia Slovenia 11 employees Venture round Total: $1.50M Biotechnology, Manufacturing

General Information

Company Name noviSplet
Founded Year 2004
Location Slovenia Slovenia
Employees 11
Industries Biotechnology, Manufacturing
Funding Stage Venture round
Social

BounceWatch is an independent company data service, not affiliated with noviSplet. To contact noviSplet, visit novisplet.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does noviSplet compare?

A PDF of noviSplet and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting noviSplet soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About noviSplet

BIA Separations is a biotechnology and manufacturing company founded in 1998. The company specializes in producing proprietary short monolithic chromatographic columns utilizing CIM Convective Interaction Mediaยฎ Technology. These columns are designed for purifying large biomolecules such as viruses, DNA, and larger proteins, offering exceptional operational flow rates, binding capacity, and separation resolution. Their usability spans across research, laboratory, pilot, and industrial production stages, requiring no column packing, making them extremely user-friendly.

Notably, BIA Separations secured a โ‚ฌ1.50M Venture Round investment on 21 September 2015 from Ingenium Slovenia Fund.

The company's slogan underscores its commitment to providing unmatched efficiency and seamless operation in purifying large biomolecules with its advanced monolithic chromatographic columns.

Business keywords: chromatographic columns, CIM Convective Interaction Media, large biomolecules, virus purification, DNA purification, protein purification, viral vectors, vaccine production, Immunoglobulins purification, pegylated proteins, industrial bioprocessing, biomolecule separation, monolithic technology, bioprocessing equipment, biopharmaceutical production

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round โ‚ฌ1.50M 1
Ingenium Slovenia Fund
21 Sep 2015

noviSplet Alternatives & Competitors

View All Alternatives
noviSplet vs
UNIVERCELLS
UNIVERCELLS Belgium

For humanity to thrive, we need transformative thinking in how vaccines and therapeutics are designe...

Series D
24 employees
Biotechnology, Health Care
noviSplet vs
Biovaccines Nigeria Limited
Biovaccines Nigeria Limited Nigeria

Advancing Health Through Innovation.

6 employees
Biotechnology, Health and Wellness
noviSplet vs
Hester & Co
Hester & Co

Crafting innovations in poultry and large animal health, enhancing wellness with vaccines, feed supp...

Grant
2-10 employees
Agriculture, Biotechnology
View all alternatives

FAQ About noviSplet

Digitalna agencija, specializirana za izdelavo spletnih strani in B2B/B2C trgovin z veฤ kot 1500 referencami. ๐ŸŒ๐Ÿ’ก๐Ÿš€
noviSplet was founded in 2004.
noviSplet is headquartered in Slovenia.
noviSplet operates in Biotechnology and Manufacturing. Its work centres on chromatographic columns, CIM Convective Interaction Media, large biomolecules and virus purification.
noviSplet has approximately 11 employees.
noviSplet has completed 1 funding round, raising a total of $1.50M. The latest funding stage is Venture round.
Top alternatives and competitors to noviSplet include UNIVERCELLS, Biovaccines Nigeria Limited, Hester & Co, EntoBio. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
noviSplet and UNIVERCELLS are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for noviSplet, https://bouncewatch.com/company/bia-separations, updated 25 October 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes